4/A//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4/A
Accession 0001053369-15-000027
$ELTPCIK 0001053369operating
Filed
May 12, 8:00 PM ET
Accepted
May 13, 6:08 PM ET
Size
5.5 KB
Accession
0001053369-15-000027
Insider Transaction Report
Form 4/AAmended
NIGALAYE ASHOK G
DirectorChief Scientific Officer10% Owner
Transactions
- Conversion
Warrants
2015-01-06$0.06/sh−1,500,000$93,750→ 2,924,333 totalExercise: $0.06From: 2009-10-30Exp: 2016-10-30→ Common Stock (1,500,000 underlying)
Footnotes (1)
- [F1]In the original filing, the warrants converted were deducted from the incorrect warrant resulting in an incorrect warrant balance. The issue date, expiration date and exercise price are the same on the original filing and this amended filing.
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4/A
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 6:08 PM ET
- Size
- 5.5 KB